HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Murali Gopalakrishnan Selected Research

2,2- dimethyl- 5- (6- phenylpyridazin- 3- yl)- 5- aza- 2- azoniabicyclo(2.2.1)heptane

1/2008[3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Murali Gopalakrishnan Research Topics

Disease

9Overactive Urinary Bladder (Overactive Bladder)
11/2007 - 10/2002
8Alzheimer Disease (Alzheimer's Disease)
09/2010 - 06/2007
6Schizophrenia (Dementia Praecox)
04/2012 - 07/2006
3Neuroblastoma
12/2011 - 09/2010
3Pain (Aches)
10/2011 - 11/2006
3Neuralgia (Stump Neuralgia)
10/2011 - 11/2006
3Neurodegenerative Diseases (Neurodegenerative Disease)
08/2009 - 01/2008
2Hyperalgesia
10/2011 - 11/2006
2Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
01/2003 - 10/2002
1Peritonitis
10/2011
1Inflammation
10/2011
1Nausea
10/2011
1Vomiting
10/2011
1Tauopathies
04/2009
1Dementia (Dementias)
09/2007
1Central Nervous System Diseases (CNS Diseases)
07/2006
1Urologic Diseases (Urinary Tract Disease)
10/2004
1Hypothermia
01/2004
1Ataxia (Dyssynergia)
01/2004
1Seizures (Seizure)
01/2004
1Prostatic Neoplasms (Prostate Cancer)
06/2003

Drug/Important Bio-Agent (IBA)

8Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
04/2012 - 06/2007
8Adenosine Triphosphate (ATP)IBA
11/2007 - 10/2002
3alpha7 nicotinic acetylcholine receptorIBA
09/2010 - 04/2009
3Potassium Channels (Potassium Channel)IBA
11/2007 - 01/2004
25-(2-azetidinylmethoxy)-2-chloropyridineIBA
10/2011 - 10/2011
25- (6- (1- azabicyclo(2,2,2)oct- 3- yloxy)pyridazin- 3- yl)- 1H- indoleIBA
09/2010 - 09/2010
2Cholinergic ReceptorsIBA
08/2009 - 07/2009
2LigandsIBA
08/2008 - 11/2006
2Amyloid (Amyloid Fibrils)IBA
08/2008 - 06/2007
2dicyandiamido (cyanoguanidine)IBA
11/2007 - 01/2004
29- (3- bromo- 4- fluorophenyl)- 2,3,5,6,7,9- hexahydrothieno(3,2- b)quinolin- 8(4H)- one 1,1-dioxideIBA
10/2002 - 10/2002
1Antipsychotic Agents (Antipsychotics)IBA
04/2012
11- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA
12/2011
1CalciumIBA
12/2011
1ZymosanIBA
10/2011
1CytokinesIBA
10/2011
1Acetylcholine (Acetylcholine Chloride)FDA Link
10/2011
1CarrageenanIBA
10/2011
1Carbon MonoxideIBA
10/2011
1Ligand-Gated Ion ChannelsIBA
08/2009
1glycogen synthase kinase 3 betaIBA
04/2009
1GTP-Binding Proteins (G-Protein)IBA
01/2009
1amyloid beta-protein (1-42)IBA
08/2008
12,2- dimethyl- 5- (6- phenylpyridazin- 3- yl)- 5- aza- 2- azoniabicyclo(2.2.1)heptaneIBA
01/2008
1pregabalin (Lyrica)FDA Link
11/2006
1Analgesics (Analgesic Drugs)IBA
11/2006
1Calcium Channels (Calcium Channel)IBA
11/2006
1gabapentin (Neurontin)FDA LinkGeneric
11/2006
1NicotineFDA Link
07/2006
1A-151892IBA
09/2004
12- methyl- 3- (2- pyrrolidinylmethoxy)pyridineIBA
01/2004
11-ethyl-2-benzimidazolinoneIBA
06/2003
1RiluzoleFDA LinkGeneric
06/2003
1RubidiumIBA
06/2003
1tolterodine (Detrol)FDA Link
01/2003
11,4-dihydropyridine (dihydropyridine)IBA
10/2002
1PotassiumIBA
10/2002

Therapy/Procedure

1Oral Administration
10/2011
1Ligation
11/2006
1Therapeutics
01/2003